News & Perspective

(CIDRAP News) – With tougher security requirements set to take effect next April, few state public health laboratories plan to maintain stocks of certain pathogens considered most tempting to bioterrorists, according to the Association of Public Health Laboratories (APHL) and officials with state labs.

(CIDRAP News) – A new report from the US Department of Health and Human Services (HHS) offers a few predictions on when certain new countermeasures against biological threats will become available, including a forecast for two novel influenza drugs and possibly a next-generation anthrax vaccine within the next 5 years.

(CIDRAP News) – The Centers for Disease Control and Prevention (CDC) has revised its list of potentially dangerous biological agents and toxins and the regulations covering them, and some of the changes have public health laboratories concerned.

(CIDRAP News) – The recently released annual report for the federal Project BioShield program gives a snapshot of the US arsenal for blunting bioterrorist attacks, showing growth in the supplies of certain countermeasures for anthrax, botulism, and smallpox.

(CIDRAP News) – The US Department of Health and Human Services (HHS) recently updated its strategy for developing and acquiring countermeasures against threats such as bioterror attacks and pandemic flu, a document that spells out the federal game plan for the next 5 years.

(CIDRAP News) – A federal advisory committee is recommending that 11 bacterial species and viruses on the current "select agent" list, including anthrax and Ebola virus, be singled out for special safeguards and that another 19 agents be dropped from the list entirely.

(CIDRAP News) – After a second round of committee negotiations today, the World Health Assembly (WHA) agreed to postpone setting a date for destruction of the world's remaining smallpox virus stocks for another 3 years.

(CIDRAP News) – Delegates from 193 countries met today in Geneva at the start of the World Health Assembly (WHA), which will address several infectious disease topics, including a report from an independent pandemic review committee, a virus-sharing agreement, and the fate of the world's remaining smallpox virus stocks.